Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1975 Jun 14;112(13 Spec No):33–34.

Pharmacokinetics and efficacy of trimethoprim-sulfamethoxazole in the treatment of gastroenteritis in children.

M I Marks
PMCID: PMC1956458  PMID: 1039907

Abstract

In vitro studies indicates that the constitutents of the drug combination co-trimoxazole are synergistic against Salmonella and effective against shigella isolated from children ill with gastroenteritis. The drug is well absorbed in children with gastroenteritis due to a variety of causes and is distributed, excreted and metabolized in a manner similar to that seen in normal adult volunteers. The drug is tolerated well by children with gastroenteritis even in very high dosages. Despite its in vitro and pharmacokinetic advantages, co-trimoxazole was not any more efficient than any other durg or no therapy in the treatment of salmonella gastroenteritis; it seems to have a role, however, in the treatment of typhoid fever and may be life-saving in patients infected with ampicillin- and chloramphenical-resistant strains. It is also effective in the treatment of shigella gastroenteritis and is recommended where ampicillin-resistant strains are encountered. Its potential usefulenss for the treatment of other bacterial causes of gastroenteritis in children must be evaluated by further controlled therapeutic trials.

Full text

PDF
33S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akinkugbe O. O., Lewis E. A., Montefiore D., Okubadejo O. A. Trimethoprim and sulphamethoxazole in typhoid. Br Med J. 1968 Sep 21;3(5620):721–722. doi: 10.1136/bmj.3.5620.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aserkoff B., Bennett J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med. 1969 Sep 18;281(12):636–640. doi: 10.1056/NEJM196909182811202. [DOI] [PubMed] [Google Scholar]
  3. Darrell J. H., Garrod L. P., Waterworth P. M. Trimethoprim: laboratory and clinical studies. J Clin Pathol. 1968 Mar;21(2):202–209. doi: 10.1136/jcp.21.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Geddes A. M., Fothergill R., Goodall J. A., Dorken P. R. Evaluation of trimethoprim-sulphamethoxazole compound in treatment of salmonella infections. Br Med J. 1971 Aug;3(5772):451–454. doi: 10.1136/bmj.3.5772.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Haltalin K. C., Nelson J. D., Hinton L. V., Kusmiesz H. T., Sladoje M. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin. J Pediatr. 1968 May;72(5):708–720. doi: 10.1016/s0022-3476(68)80021-6. [DOI] [PubMed] [Google Scholar]
  6. Haltalin K. C., Nelson J. D., Kusmiesz H. T., Hinton L. V. Comparison of intramuscular and oral ampicillin therapy for shigellosis. J Pediatr. 1968 Oct;73(4):617–622. doi: 10.1016/s0022-3476(68)80282-3. [DOI] [PubMed] [Google Scholar]
  7. Haltalin K. C., Nelson J. D., Kusmiesz H. T., Hinton L. V. Optimal dosage of ampicillin for shigellosis. J Pediatr. 1969 Apr;74(4):626–631. doi: 10.1016/s0022-3476(69)80051-x. [DOI] [PubMed] [Google Scholar]
  8. Kamat S. A. Evaluation of therapeutic efficacy of trimethoprim-sulphamethoxazole and chloramphenicol in enteric fever. Br Med J. 1970 Aug 8;3(5718):320–322. doi: 10.1136/bmj.3.5718.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kazemi M., Gumpert T. G., Marks M. I. A controlled trial comparing sulfametboxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children. J Pediatr. 1973 Oct;83(4):646–650. doi: 10.1016/s0022-3476(73)80234-3. [DOI] [PubMed] [Google Scholar]
  10. Langlois Y., Gagnon M. A., Tétreault L. A bioavailability study on three oral preparations of the combination trimethoprim-sulfamethoxazole. J Clin Pharmacol New Drugs. 1972 May-Jun;12(5):196–200. doi: 10.1002/j.1552-4604.1972.tb00161.x. [DOI] [PubMed] [Google Scholar]
  11. Marks M. I., Kazemi M., Hales B., Neims A. H. Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis. J Infect Dis. 1973 Nov;128(Suppl):622–p. doi: 10.1093/infdis/128.supplement_3.s622. [DOI] [PubMed] [Google Scholar]
  12. Marks M. I., Kazemi M., MacKay E. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination. Antimicrob Agents Chemother. 1973 Nov;4(5):555–559. doi: 10.1128/aac.4.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rudoy R. C., Nelson J. D., Haltalin K. C. In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole. Antimicrob Agents Chemother. 1974 May;5(5):439–443. doi: 10.1128/aac.5.5.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schroeder S. A., Terry P. M., Bennett J. V. Antibiotic resistance and transfer factor in Salmonella, United States 1967. JAMA. 1968 Sep 23;205(13):903–906. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES